Needham Starts Pozen with 'Strong Buy'

Analyst Eun Yang says Pozen has the most advanced, strongest product pipeline for migraine therapy

Needham intitiates coverage of Pozen (POZN ) with strong buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.